Jump to content

Rosa Rademakers

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Scorpions13256 (talk | contribs) at 08:51, 14 August 2023 (Copying from Category:American women neuroscientists to Category:American neuroscientists using Cat-a-lot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Rosa Rademakers is an American neurogeneticist and professor within the Department of Neuroscience at the Mayo Clinic. Her research centers on the genetic basis of neurodegenerative diseases, such as identifying causal genes and their function, exploring familial risk factors, and the mechanism of the degeneration.[1] Her neurodegenerative diseases of focus include "Alzheimer's disease (AD), frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS)."[1] She received a Bachelor of Arts in Biology, a Master of Arts in Biochemistry, and a Ph.D. in Science, all from the University of Antwerp.[1] Originally from the Netherlands, she came to the Mayo Clinic in 2005 for a post-doctoral fellowship, and in 2007 she was given a lab director position.[2]

Scientific research focus areas

Rademakers has researched mutations within genetic regulators of progranulin (GRN), which can cause early-onset dementia. She worked to develop a test to identify carriers of this mutation.[1] This blood test identifies mutations in order to detect and understand the gene's regulation.[3]

Her lab has also researched a mutation within the C9orf72 gene that contributes to the development of ALS and FTD.[1] Her research discovered that this is the genetic basis for a majority of ALS and FTD cases.[4] She received the 2016 Potamkin Prize based on this research.[3]

Rademakers is working on research of causal genes and disease mechanisms of early-onset Alzheimer's disease. Her research team aims to sequence parts of the genome of patients with the disease in order to identify novel potential causes.[1] She has also worked to sequence genes related to FTD.[5]

Rademakers is also researching tau protein accumulation by whole-genome sequencing of families.[1]

Notable professional achievements

  • Rademakers has filed six patents for detection and treatment of dementia[6]
  • Rademakers has been a contributing author on over 300 peer-reviewed academic journal articles[7]
  • Committee Member of the National Centralized Repository for Alzheimer's Disease and Related Dementias Executive Committee[8]
  • Mildred A. and Henry Uihlein II Professor of Medical Research at the Mayo Clinic College of Medicine[3]

Awards and honors

References

  1. ^ a b c d e f g "Rosa Rademakers, Ph.D." Mayo Clinic. Retrieved 2020-04-20.
  2. ^ Patton, Charlie. "Mayo Clinic researcher honored with prestigious award". The Florida Times-Union. Retrieved 2020-05-09.
  3. ^ a b c d Punksy, Kevin (2016-04-05). "Florida Scientist to Receive International Award for Advances in Dementia Research". Mayo Clinic. Retrieved 2020-04-20.
  4. ^ Allen, Heather; Beggs, Kathleen; Cleary, Stuart; Dibranon, Shelley; Durham, Heather; Findlater, Karen; Forseth, Nancy; Hall, Karen; Libramonte, Jennifer (2012). A Manual for People Living with ALS (PDF). Douglas McKim, Leann Merla,Gwyneth Moe, Lorraine Papineau, Brigitte Poirier, Nicole Shuckett, Amy Shuster. ALS Society of Canada.
  5. ^ "11th ICFTD Meeting in Sydney Sorts Out Clinical Subtypes | ALZFORUM". www.alzforum.org. Retrieved 2020-05-09.
  6. ^ "Rosa Rademakers Inventions, Patents and Patent Applications - Justia Patents Search". patents.justia.com. Retrieved 2020-04-20.
  7. ^ "Publications - Mayo Clinic". www.mayo.edu. Retrieved 2020-04-20.
  8. ^ "NCRAD - Executive Committee". ncrad.iu.edu. Retrieved 2020-05-09.
  9. ^ "Rosa Rademakers, Ph.D." National Institute of Neurological Disorders and Stroke. Retrieved 2020-04-20.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Rosa_Rademakers&oldid=1170308434"